Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Antibodies:
anti-Rat (Rattus) Antibodies:
Go to our pre-filtered search.
Human Polyclonal ARHGEF3 Primary Antibody for ELISA - ABIN565494
DAmato, DellAversana, Conte, Ciotta, Scisciola, Carissimo, Nebbioso, Altucci: ARHGEF3 controls HDACi-induced differentiation via RhoA-dependent pathways in acute myeloid leukemias. in Epigenetics : official journal of the DNA Methylation Society 2015
Human Polyclonal ARHGEF3 Primary Antibody for ICC, IF - ABIN4281547
Stadler, Rexhepaj, Singan, Murphy, Pepperkok, Uhlén, Simpson, Lundberg: Immunofluorescence and fluorescent-protein tagging show high correlation for protein localization in mammalian cells. in Nature methods 2013
Human Polyclonal ARHGEF3 Primary Antibody for IHC (p), WB - ABIN652003
Liu, Zheng, Cai, Guo, Lin, Chen, Liao, Kung, Zeng, Xie: The putative tumor activator ARHGEF3 promotes nasopharyngeal carcinoma cell pathogenesis by inhibiting cellular apoptosis. in Oncotarget 2017
Evidence for ARHGEF3 being a regulator of transferrin uptake in erythroid cells, through activation of RHOA.
This is the first study describing the involvement of XPLN in the regulation of the mTORC2-SPARC axis, and these findings may help uncover regulatory mechanisms mediated by XPLN in idiopathic pulmonary fibrosis
Our findings suggest that increased expression of ARHGEF3 plays a critical oncogenic role in nasopharyngeal carcinoma pathogenesis
Data suggest that modulation of ARHGEF3 gene expression in humans with a promoter-localized SNP plays a role in human megakaryocytes and human platelet function-a finding resulting from the biological follow-up of human genetic studies. Arhgef3 KO mice partially recapitulate the human phenotype.
ARHGEF3 has a crucial role in myeloid differentiation.
ARHGEF3 and RHOA are potential regulators of a number of genes in bone cells, with influences on ACTA2 evident in both osteoblast-like and osteoclast-like cells.
XPLN is an endogenous inhibitor of mTORC2.
the association between rs7646054 in ARHGEF3 and bone mineral density observed in Caucasians was not replicated in the chinese samples.
a guanine nucleotide exchange factor for RhoA and RhoB, but not RhoC
genetic variation in ARHGEF3 plays a role in the determination of bone density in Caucasian women. This data implicates the RhoGTPase-RhoGEF pathway in osteoporosis.
the crystal structure of the tandemly arranged DH-PH domains of mouse Xpln, with a single molecule in the asymmetric unit, was determined at 1.79 A resolution (Xpln)
Rho-like GTPases are involved in a variety of cellular processes, and they are activated by binding GTP and inactivated by conversion of GTP to GDP by their intrinsic GTPase activity. Guanine nucleotide exchange factors (GEFs) accelerate the GTPase activity of Rho GTPases by catalyzing their release of bound GDP. This gene encodes a guanine nucleotide exchange factor, which specifically activates two members of the Rho GTPase family: RHOA and RHOB, both of which have a role in bone cell biology. It has been identified that genetic variation in this gene plays a role in the determination of bone mineral density (BMD), indicating the implication of this gene in postmenopausal osteoporosis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
Rho guanine nucleotide exchange factor (GEF) 3
, Rho guanine nucleotide exchange factor 3
, rho guanine nucleotide exchange factor 3
, rho guanine nucleotide exchange factor 3-like
, 59.8 kDA protein
, RhoGEF protein
, exchange factor found in platelets and leukemic and neuronal tissues, XPLN